- Home
- BHC vs AMRX Comparison
BHC vs AMRX Comparison
Compare BHC & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- AMRX
- Stock Information
- Founded
- BHC N/A
- AMRX 2002
- Country
- BHC Canada
- AMRX United States
- Employees
- BHC N/A
- AMRX N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- AMRX Biotechnology: Pharmaceutical Preparations
- Sector
- BHC Health Care
- AMRX Health Care
- Exchange
- BHC Nasdaq
- AMRX Nasdaq
- Market Cap
- BHC 2.3B
- AMRX 2.5B
- IPO Year
- BHC N/A
- AMRX N/A
- Fundamental
- Price
- BHC $6.67
- AMRX $8.13
- Analyst Decision
- BHC Hold
- AMRX Strong Buy
- Analyst Count
- BHC 5
- AMRX 4
- Target Price
- BHC $7.20
- AMRX $11.50
- AVG Volume (30 Days)
- BHC 2.9M
- AMRX 1.8M
- Earning Date
- BHC 07-31-2025
- AMRX 08-08-2025
- Dividend Yield
- BHC N/A
- AMRX N/A
- EPS Growth
- BHC N/A
- AMRX N/A
- EPS
- BHC N/A
- AMRX N/A
- Revenue
- BHC $9,731,000,000.00
- AMRX $2,830,186,000.00
- Revenue This Year
- BHC $3.71
- AMRX $9.84
- Revenue Next Year
- BHC $5.03
- AMRX $7.33
- P/E Ratio
- BHC N/A
- AMRX N/A
- Revenue Growth
- BHC 8.53
- AMRX 13.42
- 52 Week Low
- BHC $3.96
- AMRX $6.32
- 52 Week High
- BHC $9.85
- AMRX $9.48
- Technical
- Relative Strength Index (RSI)
- BHC 76.58
- AMRX 60.73
- Support Level
- BHC $5.93
- AMRX $7.69
- Resistance Level
- BHC $6.55
- AMRX $8.24
- Average True Range (ATR)
- BHC 0.29
- AMRX 0.24
- MACD
- BHC 0.11
- AMRX 0.04
- Stochastic Oscillator
- BHC 98.60
- AMRX 84.51
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About AMRX Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.